BioCentury | Apr 30, 2012
Finance

Turkish injection

...Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) paid to buy Lithuanian dermatology and hospital injectable company Sanitas Group...
BioCentury | Jan 2, 2012
Company News

Valeant Pharmaceuticals management update

...Inc. (TSX:VRX; NYSE:VRX), Mississauga, Ontario Business: Neurology, Dermatology Hired: Saulius Zemaitis as CEO of Valeant's Sanitas Group...
BioCentury | Aug 29, 2011
Company News

Valeant Pharmaceuticals, Sanitas Group deal

...million) in cash (see BioCentury, May 30). Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX), Mississauga, Ontario Sanitas Group...
BioCentury | May 30, 2011
Analyst Picks & Changes

Analyst picks & changes

...target to $64 from $58 after Valeant said it would acquire Lithuanian branded generics company Sanitas Group...
BioCentury | May 30, 2011
Finance

Highlights of weekly biotech stock moves

...raising $130.4 million through the sale of 16.3 million shares at $8 in a follow-on. Sanitas Group...
BioCentury | May 30, 2011
Company News

Valeant Pharmaceuticals, Sanitas Group deal

...and Eastern Europe (see BioCentury, March 21). Valeant Pharmaceuticals International Inc. (NYSE:VRX; TSX:VRX), Mississauga, Ontario Sanitas Group...
BioCentury | May 25, 2011
Top Story

Valeant to acquire Sanitas

...Valeant Pharmaceuticals International Inc. (NYSE:VRX; TSX:VRX) will acquire Lithuanian branded generics company Sanitas Group (Vilnius:SAN1L) for about...
Items per page:
1 - 7 of 7
BioCentury | Apr 30, 2012
Finance

Turkish injection

...Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) paid to buy Lithuanian dermatology and hospital injectable company Sanitas Group...
BioCentury | Jan 2, 2012
Company News

Valeant Pharmaceuticals management update

...Inc. (TSX:VRX; NYSE:VRX), Mississauga, Ontario Business: Neurology, Dermatology Hired: Saulius Zemaitis as CEO of Valeant's Sanitas Group...
BioCentury | Aug 29, 2011
Company News

Valeant Pharmaceuticals, Sanitas Group deal

...million) in cash (see BioCentury, May 30). Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX), Mississauga, Ontario Sanitas Group...
BioCentury | May 30, 2011
Analyst Picks & Changes

Analyst picks & changes

...target to $64 from $58 after Valeant said it would acquire Lithuanian branded generics company Sanitas Group...
BioCentury | May 30, 2011
Finance

Highlights of weekly biotech stock moves

...raising $130.4 million through the sale of 16.3 million shares at $8 in a follow-on. Sanitas Group...
BioCentury | May 30, 2011
Company News

Valeant Pharmaceuticals, Sanitas Group deal

...and Eastern Europe (see BioCentury, March 21). Valeant Pharmaceuticals International Inc. (NYSE:VRX; TSX:VRX), Mississauga, Ontario Sanitas Group...
BioCentury | May 25, 2011
Top Story

Valeant to acquire Sanitas

...Valeant Pharmaceuticals International Inc. (NYSE:VRX; TSX:VRX) will acquire Lithuanian branded generics company Sanitas Group (Vilnius:SAN1L) for about...
Items per page:
1 - 7 of 7